Baxter International Inc., BAX is in the exchange NYSE and its industry is Medical Instruments & Supplies in the sector of Healthcare. Based in USA, Baxter International Inc., BAX has a market cap of 25632.78. Since its IPO date on the 10/27/1981, Baxter International Inc., BAX performance year to date is 23.00%. Today Baxter International Inc., BAX has gained 1.15%, with a current price of 46.65.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 86.00%. The management of the company have seen the company have a payout ratio of *TBA. Return of assets are at *TBA, with return on investment at 3.40%.
In terms of debt levels and profit levels, Baxter International Inc., BAX is seeing a long-term debt/equity of 0.23. While Total debt/equity is 0.37. With a profit margin of *TBA, this is combined with a gross margin of 41.00%, and operating margin of *TBA. Baxter International Inc. ability to meet debt levels, with a current ratio of 2.1, while the quick ratio is 1.7.
For the last year Baxter International Inc., BAX has seen a EPS growth of -79.90%. A performance for the year of 27.54%. The 52-week high is -0.34%, and the 52-week low is 46.27%. The average volume for Baxter International Inc., BAX is 3256573.
With a target price of 48.55, can Baxter International Inc., BAX reach this target? Looking at the value indicators of Baxter International Inc., BAX. Baxter International Inc. has a P/E of 7.06 and a forward P/E of 24.48. Perhaps the more useful indicator than P/E, is PEG which has a value of 0.61. Baxter International Inc. also has a P/S and a P/B of 2.58 and 2.84 respectively. For P/cash, Baxter International Inc. has a value of 7.44, while it is *TBA for P/free cash flow.
At the current price of 46.65, Baxter International Inc. has a dividend yield of 1.11%. We see a return on equity of *TBA.
Looking more long-term Baxter International Inc., is projected to get an EPS growth for the next five years of 11.60%. In the short-term an EPS growth of 16.36% in the next year is forecasted. This is after a EPS growth of -79.90% for this year and for the last five years a -21.40% growth has been seen.